Clinical Trials Browser

Phase 3 × Urinary Bladder Neoplasms × Fenretinide × Clear all

NCT00004154 2018-11-08

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms